Riskpilot← Back to searchSign inGet full accessHammaslaboratorio Hamtek Oy
OYActiveY-tunnus 1737138-5Kuparitie 16-EManufacture of medical and dental instruments and supplies · NACE 3250Est. 20012 employees
Revenue 2025
EUR 194K
-1% vs 2024
EBITDA margin
0.3%
-88% vs 2024
Equity ratio
24.1%
Financial strength
Net profit 2025
EUR -2K
-279% vs 2024
| Revenue | EUR 194K | -1% |
| EBITDA | EUR 521 | -88% |
| Net profit | EUR -2K | -279% |
| Total assets | EUR 46K | -17% |
| Equity | EUR 11K | -18% |
| Employees | 2 | — |
Legal name
Hammaslaboratorio Hamtek Oy
Y-tunnus number
1737138-5
Legal form
Osakeyhtiö
NACE code
3250 · Manufacture of medical and dental instruments and supplies
Founded
11. joulukuuta 2001
Share capital
EUR 27 000
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Hallituksen jäsen yksin
Company purpose
Yhtiön toimiala on hammasteknisten töiden valmistus ja myynti sekä pienimuotoinen käsitöiden valmistus, myynti ja välitys. Toimintaansa varten yhtiöllä on oikeus omistaa ja hallita kiinteistöjä, osakkeita ja osuuksia.
Address
Kuparitie 16-E
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 197 | 208 | 192 | 195 | 194 |
| Staff expenses | −117 | −118 | −110 | −114 | −116 |
| EBITDA | −10 | −4 | 6 | 4 | 1 |
| Depreciation & amort. | −3 | −2 | −2 | −1 | −1 |
| EBIT | −13 | −6 | 4 | 3 | −0 |
| Net financials | −1 | −1 | −1 | −2 | −2 |
| Profit before tax | −13 | −7 | 3 | 1 | −2 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −13 | −7 | 3 | 1 | −2 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 48 | 50 | 51 | 55 | 46 |
| Equity | 16 | 9 | 12 | 13 | 11 |
| Long-term debt | — | — | 0 | 0 | 0 |
| Short-term debt | 33 | 42 | 39 | 42 | 35 |
| Total debt | 33 | 42 | 39 | 42 | 35 |
EBITDA margin
0.3%
This company
15.8%
Market median
-98% vs market
20212025
Equity ratio
24.1%
This company
38.2%
Market median
-37% vs market
20212025
Return on equity
-21.4%
This company
18.4%
Market median
-216% vs market
20212025
Net profit margin
-1.2%
This company
8.1%
Market median
-115% vs market
20212025
Asset turnover
4.25×
This company
1.12×
Market median
+279% vs market
20212025
Debt / equity
3.14×
This company
0.62×
Market median
-406% vs market
20212025
- Annual report 2025Filed via PRH / YTJ · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via PRH / YTJ · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via PRH / YTJ · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via PRH / YTJ · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via PRH / YTJ · Period 2020-05-01 – 2021-04-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JP Deputy Member | Deputy Member | 2011 |
| Former (2) | ||
MK Audit | Audit | 2018 – 2025 |
MJ Deputy auditor | Deputy auditor | 2018 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2011 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Hammaslaboratorio Hamtek Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Marja-Leena Kuusela | Audit | 0 companies |
| Markku Juhani Heikkilä | Deputy auditor | 0 companies |
| Jouni Pekka Juhana Kostiainen | Deputy Member | 0 companies |
| Kirsi Anneli Kostiainen | Board of Directors | 0 companies |